<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36672005</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci13010023</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Common long-term sequelae after COVID-19 include fatigue and cognitive impairment. Although symptoms interfere with daily living, the underlying pathology is largely unknown. Previous studies report relative hypometabolism in frontal, limbic and cerebellar regions suggesting focal brain involvement. We aimed to determine whether absolute hypometabolism was present and correlated to same day standardized neurocognitive testing.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fourteen patients included from a long COVID clinic had cognitive testing and quantitative dynamic [<sup>18</sup>F]FDG PET of the brain on the same day to correlate cognitive function to metabolic glucose rate.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found no hypometabolism in frontal, limbic and cerebellar regions in cognitively impaired relative to cognitive intact patients. In contrast, the cognitive impaired patients showed higher cerebellar metabolism (<i>p</i> = 0.03), which correlated with more severe deficits in working memory and executive function (<i>p</i> = 0.03).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hypermetabolism in the cerebellum may reflect inefficient brain processing and play a role in cognitive impairments after COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miskowiak</LastName><ForeName>Kamilla W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Copenhagen, &#xd8;ster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurocognition and Emotion in Affective Disorders Centre (NEAD), Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bech</LastName><ForeName>Johanne L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Neurocognition and Emotion in Affective Disorders Centre (NEAD), Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriksen</LastName><ForeName>Alexander Cuculiza</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-0186-417X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnsen</LastName><ForeName>Stine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, DK-1165 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlekareva</LastName><ForeName>Daria</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marner</LastName><ForeName>Lisbeth</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5843-5742</Identifier><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, DK-1165 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">FDG</Keyword><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">brain metabolism</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">positron emission tomography</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">work function</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36672005</ArticleId><ArticleId IdType="pmc">PMC9856023</ArticleId><ArticleId IdType="doi">10.3390/brainsci13010023</ArticleId><ArticleId IdType="pii">brainsci13010023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O.B., Nissen J., Cantwell L., Schwinn M., Tulstrup M., Westergaard D., Ullum H., Brunak S., et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen S., Sattler S.M., Miskowiak K.W., Kunalan K., Victor A., Pedersen L., Andreassen H.F., Jorgensen B.J., Heeboll H., Andersen M.B., et al. Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients. ERJ Open Res. 2021;7:00205&#x2013;02021. doi: 10.1183/23120541.00205-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00205-2021</ArticleId><ArticleId IdType="pmc">PMC8091683</ArticleId><ArticleId IdType="pubmed">34345629</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A., Kas A., Dudouet P., Goehringer F., Salmon-Ceron D., Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: A French multicentric experience. Eur. J. Nucl. Med. Mol Imaging. 2022;49:3197&#x2013;3202. doi: 10.1007/s00259-022-05753-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05753-5</ArticleId><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Ma Y., Deng J., Liu M., Liu J. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Fonsmark L., Christensen R.H.B., Amiri M., Merie C., Lebech A.M., Katzenstein T., Bang L.E., Kjaergaard J., Kondziella D., et al. Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non-COVID-19 Illness. JAMA Psychiatry. 2022;79:486&#x2013;497. doi: 10.1001/jamapsychiatry.2022.0284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0284</ArticleId><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello E.N., Radici A., Mora G., Pain D. Cognitive phenotyping of post-infectious SARS-CoV-2 patients. Neurol. Sci. 2022;43:4599&#x2013;4604. doi: 10.1007/s10072-022-06130-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06130-8</ArticleId><ArticleId IdType="pmc">PMC9125346</ArticleId><ArticleId IdType="pubmed">35604618</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertuccelli M., Ciringione L., Rubega M., Bisiacchi P., Masiero S., Del Felice A. Cognitive impairment in people with previous COVID-19 infection: A scoping review. Cortex. 2022;154:212&#x2013;230. doi: 10.1016/j.cortex.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9187867</ArticleId><ArticleId IdType="pubmed">35780756</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagianti B., Di Liberto A., Nicolo Edoardo A., Lisi I., Nobilia L., de Ferrabonc G.D., Zanier E.R., Stocchetti N., Brambilla P. Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review. Front. Aging Neurosci. 2022;14:909661. doi: 10.3389/fnagi.2022.909661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.909661</ArticleId><ArticleId IdType="pmc">PMC9283975</ArticleId><ArticleId IdType="pubmed">35847679</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotta A., Murray R., MacCabe J. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol. Med. 2015;45:381&#x2013;394. doi: 10.1017/S0033291714001512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291714001512</ArticleId><ArticleId IdType="pubmed">25065268</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S., Palladini M., Mazza M.G., De Lorenzo R., group C.-B.O.C.S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: Role of depression and impact on quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 2022;272:773&#x2013;782. doi: 10.1007/s00406-021-01346-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-021-01346-9</ArticleId><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Fugledalen L., Jespersen A.E., Sattler S.M., Podlekareva D., Rungby J., Porsberg C.M., Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur. Neuropsychopharmacol. 2022;59:82&#x2013;92. doi: 10.1016/j.euroneuro.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9008126</ArticleId><ArticleId IdType="pubmed">35561540</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Morbelli S., Kaphan E., Campion J.-Y., Dudouet P., Ceccaldi M., Cammilleri S., Nobili F., Eldin C. From early limbic inflammation to long COVID sequelae. Brain. 2021;144:e65. doi: 10.1093/brain/awab215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab215</ArticleId><ArticleId IdType="pubmed">34142116</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Million M., Dudouet P., Tissot-Dupont H., Bregeon F., Cammilleri S., Raoult D. (18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: Substrate for persistent/delayed disorders? Eur. J. Nucl. Med. Mol. Imaging. 2021;48:592&#x2013;595. doi: 10.1007/s00259-020-04973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Verger A., Cammilleri S. PET imaging of COVID-19: The target and the number. Eur. J. Nucl. Med. Mol. Imaging. 2020;47:1636&#x2013;1637. doi: 10.1007/s00259-020-04820-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04820-z</ArticleId><ArticleId IdType="pmc">PMC7163172</ArticleId><ArticleId IdType="pubmed">32303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S., Ekmekcioglu O., Barthel H., Albert N.L., Boellaard R., Cecchin D., Guedj E., Lammertsma A.A., Law I., Penuelas I., et al. COVID-19 and the brain: Impact on nuclear medicine in neurology. Eur. J. Nucl. Med. Mol. Imaging. 2020;47:2487&#x2013;2492. doi: 10.1007/s00259-020-04965-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04965-x</ArticleId><ArticleId IdType="pmc">PMC7375837</ArticleId><ArticleId IdType="pubmed">32700058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A., Soret M., Pyatigoskaya N., Habert M.O., Hesters A., Le Guennec L., Paccoud O., Bombois S., Delorme C. The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2543&#x2013;2557. doi: 10.1007/s00259-020-05178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05178-y</ArticleId><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Chiola S., Gelardi F., Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: A case-control study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A., Bormann T., Blazhenets G., Schroeter N., Walter L.I., Thurow J., August D., Hilger H., Stete K., Gerstacker K., et al. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. J. Nucl. Med. 2022;63:1058&#x2013;1063. doi: 10.2967/jnumed.121.262677.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262677</ArticleId><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent D.E., Cooper P.F., FitzGerald P., Parkes K.R. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 1982;21:1&#x2013;16. doi: 10.1111/j.2044-8260.1982.tb01421.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1982.tb01421.x</ArticleId><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A., Pickard A.S. The EQ-5D and the EuroQol Group. Value Health. 2019;22:21&#x2013;22. doi: 10.1016/j.jval.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2018.12.002</ArticleId><ArticleId IdType="pubmed">30661629</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic. Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T., Steer R.A., Brown G. Manual for Beck Depression Inventory-II. Psychological Corporation; San Antonio, TX, USA: 1996.</Citation></Reference><Reference><Citation>Jensen J.H., Stottrup M.M., Nayberg E., Knorr U., Ullum H., Purdon S.E., Kessing L.V., Miskowiak K.W. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. J. Affect. Disord. 2015;187:10&#x2013;19. doi: 10.1016/j.jad.2015.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2015.07.039</ArticleId><ArticleId IdType="pubmed">26301477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott C.V., Knorr U., Jespersen A., Obenhausen K., Roen I., Purdon S.E., Kessing L.V., Miskowiak K.W. Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder. J. Affect. Disord. 2021;281:33&#x2013;40. doi: 10.1016/j.jad.2020.11.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.11.119</ArticleId><ArticleId IdType="pubmed">33285390</ArticleId></ArticleIdList></Reference><Reference><Citation>Manual of Directions and Scoring. War Department, Adjutant General&#x2019;s Office; Washington, DC, USA: 1944. Army Individual Test Battery.</Citation></Reference><Reference><Citation>corwin J. On measuring discrimination and response bias: Unequal numbers of targets and distractors and two classes of distractors. Neuropsychology. 1994;8:110&#x2013;117. doi: 10.1037/0894-4105.8.1.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0894-4105.8.1.110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey A. L'examen Clinique en Psychologie. [The Clinical Examination in Psychology] Presses Universitaries De France; Oxford, UK: 1958.</Citation></Reference><Reference><Citation>Randolph C., Tierney M.C., Mohr E., Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J. Clin. Exp. Neuropsychol. 1998;20:310&#x2013;319. doi: 10.1076/jcen.20.3.310.823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.3.310.823</ArticleId><ArticleId IdType="pubmed">9845158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. WAIS-III: Administration and Scoring Manual: Wechsler Adult Intelligence Scale. Psychological Corporation; San Antonio, TX, USA: 1997.</Citation></Reference><Reference><Citation>Harmer C.J., Shelley N.C., Cowen P.J., Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am. J. Psychiatry. 2004;161:1256&#x2013;1263. doi: 10.1176/appi.ajp.161.7.1256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.161.7.1256</ArticleId><ArticleId IdType="pubmed">15229059</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkowski J.G., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5:135&#x2013;140. doi: 10.1016/0028-3932(67)90015-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0028-3932(67)90015-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson H.E., O&#x2019;Connell A. Dementia: The estimation of premorbid intelligence levels using the New adult reading test. Cortex. 1978;14:234&#x2013;244. doi: 10.1016/S0010-9452(78)80049-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0010-9452(78)80049-5</ArticleId><ArticleId IdType="pubmed">679704</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriksen A.C., Lonsdale M.N., Fuglo D., Kondziella D., Nersesjan V., Marner L. Non-invasive quantification of cerebral glucose metabolism using Gjedde-Patlak plot and image-derived input function from the aorta. Neuroimage. 2022;253:119079. doi: 10.1016/j.neuroimage.2022.119079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2022.119079</ArticleId><ArticleId IdType="pubmed">35276368</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273&#x2013;289. doi: 10.1006/nimg.2001.0978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2001.0978</ArticleId><ArticleId IdType="pubmed">11771995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessing L.V., Munkholm K., Faurholt-Jepsen M., Miskowiak K.W., Nielsen L.B., Frikke-Schmidt R., Ekstrom C., Winther O., Pedersen B.K., Poulsen H.E., et al. The Bipolar Illness Onset study: Research protocol for the BIO cohort study. BMJ Open. 2017;7:e015462. doi: 10.1136/bmjopen-2016-015462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015462</ArticleId><ArticleId IdType="pmc">PMC5734582</ArticleId><ArticleId IdType="pubmed">28645967</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmahmann J.D. The cerebellum and cognition. Neurosci. Lett. 2019;688:62&#x2013;75. doi: 10.1016/j.neulet.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.07.005</ArticleId><ArticleId IdType="pubmed">29997061</ArticleId></ArticleIdList></Reference><Reference><Citation>Koziol L.F., Budding D., Andreasen N., D'Arrigo S., Bulgheroni S., Imamizu H., Ito M., Manto M., Marvel C., Parker K., et al. Consensus paper: The cerebellum&#x2019;s role in movement and cognition. Cerebellum. 2014;13:151&#x2013;177. doi: 10.1007/s12311-013-0511-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-013-0511-x</ArticleId><ArticleId IdType="pmc">PMC4089997</ArticleId><ArticleId IdType="pubmed">23996631</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi H., Faber J., Timmann D., Klockgether T. Update cerebellum and cognition. J. Neurol. 2021;268:3921&#x2013;3925. doi: 10.1007/s00415-021-10486-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10486-w</ArticleId><ArticleId IdType="pmc">PMC8463403</ArticleId><ArticleId IdType="pubmed">33656586</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Petersen C.S. Neuronal underpinnings of cognitive impairment and&#x2014;Improvement in mood disorders. CNS Spectr. 2019;24:30&#x2013;53. doi: 10.1017/S1092852918001062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1092852918001062</ArticleId><ArticleId IdType="pubmed">30198479</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., group C.-B.O.C.S., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID and the brain: Researchers zero in on how damage occurs. Nature. 2021;595:484&#x2013;485. doi: 10.1038/d41586-021-01693-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Duindam H.B., Kessels R.P.C., van den Borst B., Pickkers P., Abdo W.F. Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19. Brain Behav. Immun. Health. 2022;25:100513. doi: 10.1016/j.bbih.2022.100513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100513</ArticleId><ArticleId IdType="pmc">PMC9482799</ArticleId><ArticleId IdType="pubmed">36159208</ArticleId></ArticleIdList></Reference><Reference><Citation>Putilina M.V., Grishin D.V. SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies. Neurosci. Behav. Physiol. 2021;51:577&#x2013;582. doi: 10.1007/s11055-021-01108-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11055-021-01108-z</ArticleId><ArticleId IdType="pmc">PMC8219508</ArticleId><ArticleId IdType="pubmed">34176996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mas M., Garcia-Vicente J.A., Estrada-Gelonch A., Perez-Mana C., Papaseit E., Torrens M., Farre M. Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence. J. Clin. Med. 2022;11:4038. doi: 10.3390/jcm11144038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11144038</ArticleId><ArticleId IdType="pmc">PMC9319396</ArticleId><ArticleId IdType="pubmed">35887802</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>